| Thomas Charles Hoffer, MD | |
|
2400 Trawood Dr, El Paso, TX 79936-4122 | |
| (915) 577-8080 | |
| Not Available |
| Full Name | Thomas Charles Hoffer |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 2400 Trawood Dr, El Paso, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124010012 | NPI | - | NPPES |
| 144606401 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | G89595 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Charles Hoffer, MD 200 S Alto Mesa Dr, El Paso, TX 79912-4426 Ph: (915) 833-6631 | Thomas Charles Hoffer, MD 2400 Trawood Dr, El Paso, TX 79936-4122 Ph: (915) 577-8080 |
News Archive
International Stem Cell Corporation, will present data on its progress toward producing human liver cells from immune-matched patient-specific parthenogenetic stem cells at The Liver Meeting, the 61st Annual Meeting of the American Association for the Study of Liver Diseases (ASSLD), in Boston, MA from October 29 - November 2, 2010.
A team of researchers from Queen's University Belfast, led by Professor Ryan Donnelly, Professor of Pharmaceutical Technology are developing a new type of skin patch (microarray patch) that administers drugs directly into the bloodstream through thousands of individual "microneedles" which are being tested as a possible answer to the antibiotic resistance crisis.
Sylentis, Pharmaceutical Company belonging to the PharmaMar Group, has presented results from the clinical studies carried out with tivanisiran for the treatment of dry eye syndrome and that has enabled the start-up of the Phase III "Helix" clinical trial.
Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.
› Verified 2 days ago
Teresa Anne Reed, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1400 George Dieter Dr, Ste. 170, El Paso, TX 79936 Phone: 915-921-7855 Fax: 915-921-7866 | |
Sylvester D Phifer, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 10301 Gateway Blvd W, El Paso, TX 79925 Phone: 915-535-9275 | |
Dr. Melhem R. Ghaleb, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4815 Alameda Ave, El Paso, TX 79905 Phone: 915-521-7620 Fax: 915-521-7842 | |
Zagum Bhatti, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1302 N Stanton St, El Paso, TX 79902 Phone: 915-248-1277 Fax: 915-845-9072 | |
William M Boushka, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 6065 Montana Ave, Bldg A Ste 6, El Paso, TX 79925 Phone: 915-881-1900 Fax: 915-771-9345 | |
Dr. Douglas K Woo, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 5400 Suncrest Dr, Suite B3, El Paso, TX 79912 Phone: 915-581-2130 Fax: 915-581-6940 | |
Dr. Richard Cohen, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2001 N Oregon St, El Paso, TX 79902 Phone: 915-833-6631 Fax: 915-833-6618 |